Another controversy has erupted around
blood pressure measurement and this has been created by doctors.
Doctors have done this by creating a 'one-size-fits-all' program for
hypertension treatment. Most are prescribing blood pressure
medications to those that really don't need the medications and
others are over prescribing the medications to lower blood pressure
levels to those of the guidelines.
These doctors do not care that it may
lower blood pressures too low for the elderly and cause them falls
that may be very serious. All they care about is the levels and
issuing the prescriptions. They do not take into consideration the
person's age and other comorbid conditions, in other words the
patient is not properly assessed.
Blood pressure readings vary, but most
people with diabetes should have a reading of no more than 140/80.
The first, or top, number is the "systolic pressure," or
the pressure in the arteries when your heart beats and fills the
arteries with blood. The second, or bottom, number is the "diastolic
pressure," or the pressure in the arteries when your heart rests
between beats, filling itself with blood for the next contraction.
There is some “expert” disagreement
with the above numbers and some groups feel that BP readings should
be 130/75-80. When it comes to preventing diabetes complications,
normal blood pressure is as important as good control of your blood
sugar levels.
A small reduction as the primary
composite outcome may not justify the increased adverse events and
costs associated with an intervention targeting systolic blood
pressure (BP) less than 120 mm Hg, according to an Ideas and Opinions
piece published online Feb. 23 in the Annals of Internal Medicine.
Eduardo Ortiz, M.D., M.P.H., from
Washington D.C., and Paul A. James, M.D., from the University of Iowa
in Iowa City, discuss the results of the Systolic Blood Pressure
Intervention Trial (SPRINT), which were promoted before publication.
The results showed a risk reduction in the primary composite outcome
with a lower target systolic BP.
The researchers note that based on the results, for 1,000 persons treated over 3.2 years with a systolic BP target of less than 120 mm Hg versus 140 mm Hg, 16 persons would benefit, 22 would be seriously harmed, and 962 would experience no benefits or harms. In addition to a small decrease in event rates, the aggressively treated group more frequently had serious adverse drug events, which were possibly or definitely related to the intervention.
The researchers note that based on the results, for 1,000 persons treated over 3.2 years with a systolic BP target of less than 120 mm Hg versus 140 mm Hg, 16 persons would benefit, 22 would be seriously harmed, and 962 would experience no benefits or harms. In addition to a small decrease in event rates, the aggressively treated group more frequently had serious adverse drug events, which were possibly or definitely related to the intervention.
"We do not believe that the small
absolute benefit seen in SPRINT provides convincing evidence that
large segments of the population should be treated with additional
drugs to a systolic BP goal less than 120 mm Hg, especially when the
adverse events, costs, and burden of such treatment are considered,"
the authors write.